DrugDrug NameDrug Indication
DB01971trans-urocanic acidNot Available
DB04741MyxothiazolNot Available
DB05112AP5280Investigated for use/treatment in solid tumors.
DB07778FAMOXADONENot Available
DB09330OsimertinibOsimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA- approved test, who have progressed on or after EGFR-TKI therapy.
DB11764SpebrutinibNot Available
DB11907RociletinibNot Available
DB12017OzagrelNot Available
DB120402-octyl cyanoacrylateNot Available
DB12207VerdinexorNot Available
DB12358EnbucrilateNot Available
DB12428PAC-14028Not Available
DB12731DaporinadNot Available